ITMCTR2200006837
Not yet recruiting
未知
Based on multi-omics technology, the objective research and standard formulation of typical poisonous symptoms in traditional Chinese medicine for advanced gastric cancer were carried out
Yangzhou Hospital of Traditional Chinese Medicine, Jiangsu Province0 sitesTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Yangzhou Hospital of Traditional Chinese Medicine, Jiangsu Province
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) Age 18\-75 years old, gender unlimited;
- •(2\) Gastric cancer patients with definite pathological diagnosis.
- •(3\) Patients with gastric cancer stage IIIB\-IV.
- •(4\) Those who meet the diagnostic criteria of TCM Syndromes of spleen deficiency, heat toxin syndrome, blood stasis and toxin accumulation syndrome, and phlegm toxin obstruction.
- •(5\) The estimated survival time is more than 3 months.
- •(6\) KPS score \= 60 points.
- •(7\) Compliance is good, and informed consent must be signed before enrollment.
Exclusion Criteria
- •(1\) Major trauma damage such as surgical treatment has occurred in the past month.
- •(2\) Those who have serious bleeding or systemic infection, are not controlled, or have purulent and chronic infection, and the wound does not heal.
- •(3\) At the same time, patients with hypersplenism, hyperthyroidism, connective tissue disease, tuberculosis and other diseases have not been controlled.
- •(4\) Patients with severe cardiovascular system complications, cerebrovascular system complications, active hepatitis, severe liver and kidney dysfunction.
- •(5\) Unable to understand, read and fill in the patient self\-assessment scale due to knowledge level or intelligence.
- •(6\) Any unstable situation or situation that may endanger the safety of patients and their compliance with the study, such as schizophrenia and other serious mental diseases.
- •(7\) Other parts of the body are accompanied by or have had malignant tumors (except fully treated cervical carcinoma in situ, basal or squamous cell carcinoma of the skin, or other tumors that have been cured by surgery and have not recurred for at least 5 years).
- •(8\) Women of childbearing age with positive urine pregnancy test, lactation or insufficient contraception.
- •(9\) The researcher decided that he was not suitable to participate in this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
MultipleMS – a study with the aim to accelerate personalised medicine in multiple sclerosis.ewly diagnosed patients with Clinically Isolated Syndrome (CIS) and multiple sclerosis (MS) -both relapsing remitting and primary progressive)Therapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2017-002634-24-SEKarolinska Institutet150
Recruiting
Not Applicable
Proteomic and transcriptomic analysis to understand the biology of alcoholic hepatitisHealth Condition 1: K74- Fibrosis and cirrhosis of liverCTRI/2023/01/048844ICMR
Recruiting
Not Applicable
A dynamic, multiple-biomarker approach aiming for individualized treatment of heart failure with preserved ejection fractioHeart failureHFpEF10019280NL-OMON51533niversitair Medisch Centrum200
Completed
Phase 3
A clinical trial to study the effects of evaluation of efficacy and safety of Fermalac Intravaginal Capsule (Lactobacillus Rhamnosus, Lactobacillus Delbrueckii, Streptococcus Thermophilus) in the treatment of Bacterial Vaginosis among the Indian womeCTRI/2009/091/000919Arun & Co.603 / B Polaris, Off Marol Maroshi Road,Behind Sangeet Plaza, Marol,Andheri (East), Mumbai - 400059India 200
Recruiting
Not Applicable
Aims, contents, and effects of a multidisciplinary inpatient neurological rehabilitation in people with Multiple Sclerosis: a registry studyG35Multiple sclerosisDRKS00033298Reha Zentrum Münster und Karl Landsteiner Institut für interdisziplinäre Rehabilitationsforschung am Reha Zentrum Münster6,000